-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704.O3.6 704. Cellular Immunotherapies: Cellular Therapies for Myeloma

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Biological, Lymphomas, Non-Hodgkin Lymphoma, Clinical Research, Plasma Cell Disorders, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Clinically Relevant, Diseases, Therapies, Lymphoid Malignancies
Sunday, December 12, 2021: 4:30 PM-6:00 PM
Hall C2-C3 (Georgia World Congress Center)
Moderators:
Mohamad Mohty, MD, PhD, Saint Antoine Hospital and Malvi Bipin Savani, MD, University of Arizona Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Chunrui Li, MD, PhD1, Di Wang, MD, PhD2*, Yongping Song3*, Jianyong Li4, He Huang5,6, Bing Chen7*, Jing Liu8*, Kai Hu9*, Hanyun Ren, MD10, Xi Zhang11*, Zhenyu Li, MD12*, Dehui Zou13*, Qingsong Yin14*, Lijuan Chen, MD, PhD15*, Yongxian HU, MD16*, Yong Xu, PhD17*, Qian Cheng18*, Yuelu Guo19*, Yujun Dong, MD10*, Li Gao20,21*, Aining Xu22*, Songbai Cai23*, Wen Wang24*, Ming Wu23*, Jue Wang, MD, PhD25*, Liting Chen26*, Jianfeng Zhou1* and Lugui Qiu13

1Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
3Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
4Department of Hematology, Pukou CLL Center, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
5Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
6Institute of Hematology, Zhejiang University, Hangzhou, China
7Department of Hematology, Nanjing University Medical School , the Affiliated Nanjing Drum Tower Hospital, NanJing, China
8Department of Hematology, The Third Xiangya Hospital of Central South University, Hunan, China
9Department of Hematology, Beijing Boren Hospital, Beijing, China
10Department of Hematology, Peking University First Hospital, Beijing, China
11Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
12Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
13State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
14the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China
15Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
16Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, China
17Department of Hematology, Nanjing University Medical School, the Affiliated Nanjing Drum Tower Hospital, Nanjing, China
18Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China
19Beijing Boren Hospital, Beijing, AK, China
20Department of Hematology, Xinqiao Hospital, Army medical University, Chongqing, China
21The Second Affiliated Hospital of Army Medical University, Chongqing, China
22Nanjing IASO Biotherapeutics Ltd, Nanjing, Jiangsu, Nanjing, China
23Nanjing IASO Biotherapeutics Ltd, Shanghai, China
24Nanjing IASO Biotherapeutics Ltd, Nanjing, CHN
25Department of Hematology,Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
26Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science, Wuhan, China

4:45 PM

Noopur S. Raje, MD1, Nina Shah, MD2, Sundar Jagannath3, Jonathan L. Kaufman, MD4, David S. Siegel, MD, PhD5, Nikhil C. Munshi, MD, PhD6, Jacalyn Rosenblatt, MD7, Yi Lin8, Andrzej Jakubowiak9, Alison Timm, MA10*, Ashish Yeri, PhD10*, Nathan Martin, PhD11*, Timothy B. Campbell, MD, PhD11*, Olivia Finney, PhD10*, Anna Truppel-Hartmann, MD10*, Fabio Petrocca, MD10*, Jesús G. Berdeja12 and Melissa Alsina, MD13

1Division of Hematology and Oncology, Mass General Hospital Cancer Center, Boston, MA
2University of California San Francisco, San Francisco, CA
3Department of Medicine, Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY
4Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
5Hackensack Univ. Med. Ctr., Hackensack, NJ
6Dana-Farber Cancer Institute, Harvard Medical School, Boston
7Beth Israel Deaconess Medical Center, Boston, MA
8Mayo Clinic, Rochester, MN
9University of Chicago, Chicago, IL
10bluebird bio, Cambridge, MA
11Bristol Myers Squibb, Princeton, NJ
12Sarah Cannon Research Institute, Nashville, TN
13Department of Blood & Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL

5:00 PM

Thomas Martin1, Saad Z. Usmani, MD MBA FACP2, Jesús G. Berdeja3, Andrzej Jakubowiak4, Mounzer Agha5, Adam D Cohen6, Parameswaran Hari7, David Avigan, MD8, Abhinav Deol9, Myo Htut10, Alexander Lesokhin, MD11, Nikhil C. Munshi, MD, PhD12, Elizabeth O’Donnell, MD13*, A. Keith Stewart, MBChB14, Jordan M. Schecter15, Jenna D. Goldberg15*, Carolyn C. Jackson15*, Tzu-Min Yeh15*, Arnob Banerjee16*, Alicia Allred16*, Enrique Zudaire16*, William Deraedt17*, Deepu Madduri15,18*, Yunsi Olyslager17*, Changwei Zhou19*, Lida Pacaud19*, Yi Lin20 and Sundar Jagannath, MD18*

1UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
2Levine Cancer Institute, New York, NY
3Sarah Cannon Research Institute, Nashville, TN
4University of Chicago, Chicago, IL
5UPMC Hillman Cancer Center, Pittsburgh, PA
6Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
7Medical College of Wisconsin, Milwaukee, WI
8Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
9Karmanos Cancer Institute, Wayne State University, Detroit, MI
10Comprehensive Cancer Center, City of Hope National Medical Center, Duarte, CA
11Memorial Sloan Kettering Cancer Center, New York, NY
12Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
13Harvard Medical School, Boston, MA
14University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
15Janssen R&D, Raritan, NJ
16Janssen R&D, Spring House, PA
17Janssen R&D, Beerse, Belgium
18Mount Sinai Medical Center, New York, NY
19Legend Biotech USA, Piscataway, NJ
20Mayo Clinic, Rochester, MN

5:15 PM

Maria-Victoria Mateos1, Katja Weisel2*, Thomas Martin, MD3, Jesús G. Berdeja4, Andrzej Jakubowiak5, A. Keith Stewart, MBChB6, Sundar Jagannath, MD7*, Yi Lin8, Joris Diels9*, Francesca Ghilotti10*, Nolen J Perualila9*, Jedelyn Cabrieto9*, Benjamin Haefliger11*, Nichola Erler-Yates12*, Clare Hague13*, Carolyn C. Jackson14*, Vadim Strulev9*, Tonia Nesheiwat15*, Lida Pacaud15*, Philippe Moreau, MD, PhD16* and Hermann Einsele17

1University Hospital of Salamanca/IBSAL, CIC, Salamanca, Spain
2University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
4Sarah Cannon Research Institute, Nashville, TN
5University of Chicago, Chicago, IL
6University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
7Mount Sinai Medical Center, New York, NY
8Mayo Clinic, Rochester, MN
9Janssen Pharmaceutica NV, Beerse, Belgium
10Janssen-Cilag SpA, Cologno Monzese, Italy
11Cilag GmbH International, Zug, Switzerland
12Janssen-Cilag GmbH, Neuss, Germany
13Janssen-Cilag N.V., High Wycombe, United Kingdom
14Janssen R&D, Raritan, NJ
15Legend Biotech USA, Piscataway, NJ
16Clinical Hematology, University Hospital Hotel-Dieu, Nantes, France
17Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

5:30 PM

Andrew J. Cowan, MD1, Margot Pont, PhD2*, Blythe Duke Sather, PhD3, Cameron J. Turtle, MBBS, PhD4, Brian G. Till, MD5, Edward Libby6, David G. Coffey, MD7, Sherilyn A. Tuazon, MD8, Brent L. Wood, MD, PhD9, Ted A Gooley, Ph.D.5*, Qian Vicky Wu5*, Mazyar Shadman, MD10, Jordan Gauthier, MD, MSc5*, Aude G. Chapuis, MD1, Filippo Milano, MD, PhD1, David G. Maloney, MD, PhD1, Stanley R. Riddell, MD1* and Damian J. Green, MD1

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Fred Hutchinson Cancer Research center, Seattle, WA
3Lyell Immunopharma, Seattle, WA
4Fred Hutchinson Cancer Research Ctr., Seattle, WA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
7Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
8Clinical Research Division, Fred Hutch Cancer Research Center, Seattle, WA
9Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
10University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA

5:45 PM

Aina Oliver-Caldés1*, Marta Español-Rego1*, Aintzane Zabaleta, PhD2*, Susana Inogés, MD, PhD2*, Ascensión López-Diaz de Cerio, PhD2*, Veronica Gonzalez-Calle, MD, PhD3*, Valentin Cabañas, MD4*, Beatriz Martin-Antonio, PhD5*, Lorena Pérez-Amill1*, Juan Luis Reguera6*, Juan Roberto Rodriguez-Madoz, PhD7*, Paula Rodríguez-Otero, MD, PhD2*, Daniel Benítez-Ribas1*, Mari-Pau Mena1*, Marta Lasa2*, Luis Gerardo Rodríguez-Lobato, MD, PhD1*, Azucena González1*, Laura Rosinol8*, Jose Maria Moraleda, MD, PhD4*, Felipe Prósper, MD, PhD2*, Álvaro Urbano-Ispizua, MD, PhD1*, Maria-Victoria Mateos3, Manel Juan, MD1*, Bruno Paiva, PhD2*, Mariona Pascal1* and Carlos Fernandez de Larrea, MD, PhD1

1Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
2Clínica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC Pamplona, Pamplona, Spain
3Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
4Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Arrixaca. University of Murcia, Murcia, Spain
5Instituto de Investigación Sanitaria-Fundación Jimenez Diaz, Madrid, Spain
6Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Sevilla, Sevilla, Spain
7Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain
8Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain

*signifies non-member of ASH